CPIX Cumberland Pharmaceuticals
- 1.500
- -0.070-4.46%
- 1.570
- +0.070+4.67%
Cumberland Pharmaceuticals News
Cumberland Pharmaceuticals | 10-Q: Quarterly report
Cumberland Pharmaceuticals | 8-K: Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update
Cumberland Pharmaceuticals | 8-K: Current report
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Krogulski Kenneth
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Jones James
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Galante Joseph C
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Young Caroline
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Brown Martin S JR
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer KAZIMI A J
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Herman James L
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bitterman Chris T.
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Anthony Todd M.
Cumberland Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Hamm John M.
Cumberland Pharmaceuticals | ARS: Annual Report to Security Holders
Cumberland Pharmaceuticals | 8-K: Current report
Cumberland Pharmaceuticals | 424B5: Prospectus
Cumberland Pharmaceuticals | DEFA14A: Others
Cumberland Pharmaceuticals | DEF 14A: Definitive information statements
Cumberland Pharmaceuticals | 10-K: Annual report
Cumberland Pharmaceuticals | 8-K: Current report
Analysis
Price Target
No Data
